New Edith Cowan University (ECU) research has found that exercise not only has physical benefits for men with prostate cancer, it also helps reduce symptoms of depression and anxiety.
Up to one in four men experience anxiety either before or after prostate cancer treatment and up to one in five report depression, although few men access the support they need.
The study, published in the Nature journal Prostate Cancer and Prostatic Diseases, is the first randomised controlled trial to examine the long-term effects of different exercise on psychological distress in men with prostate cancer undergoing androgen deprivation therapy (ADT).
Researchers randomly selected 135 prostate cancer patients aged 43-90 years on ADT to receive either twice weekly supervised resistance exercise or aerobic exercise for 12 months.
Their levels of psychological distress were measured during that time.
Director of the ECU Exercise Medicine Research Institute Professor Daniel Galvão said the study's findings have immediate applications for people living with prostate cancer.
"We now have the data to support the long-term effect of different exercise modes on psychological distress in men with prostate cancer undertaking ADT," Professor Galvão said.
"Whether you do aerobic exercise or resistance exercise it doesn't matter, as long as it's at moderate to high intensity, it's beneficial for reducing symptoms of depression and anxiety."
"We know that exercise benefits people with cancer. Getting a prescribed exercise program is as simple as a referral from a GP to an Accredited Exercise Physiologist," Professor Galvão said.
Source: EDITH COWAN UNIVERSITY
We are an independent charity and are not backed by a large company or society. We raise every penny ourselves to improve the standards of cancer care through education. You can help us continue our work to address inequalities in cancer care by making a donation.
Any donation, however small, contributes directly towards the costs of creating and sharing free oncology education.
Together we can get better outcomes for patients by tackling global inequalities in access to the results of cancer research.
Thank you for your support.